Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00821678 · ClinicalTrials.gov registry record · Phase 4
Telemedicine Outreach for Post Traumatic Stress in CBOCs
A Phase 4 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 4
- Development phase
- 265
- Enrollment target
NCT00821678: Completed Phase 4 study, sponsored by VA Office of Research and Development.
NCT00821678 is a Phase 4 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 265 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00821678, a Phase 4 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 265 participants
- Enrollment target
Study Summary
The purpose of this study is improved outcomes for veterans with Post Traumatic Stress Disorder (PTSD) treated in small VA Community Based Outpatient Clinics (CBOCs). Although psychotherapy and pharmacotherapy treatments for PTSD have been proven to be efficacious in controlled trials, geographic barriers often prevent veterans from accessing these evidence-based treatments. Telemedicine technologies will be used to overcome geographic barriers to care. Specifically, we will evaluate the Telemedicine Outreach for PTSD (TOP) intervention which is based on the principals of the Chronic Care Model and Disease Management, and builds on the evidence base of quality improvement for depression in primary care settings. The TOP intervention will employ an off-site PTSD care team (tele-psychiatrist, tele-psychologist, tele-pharmacist, and tele-nurse care manager) and will use telemedicine technologies (telephone, interactive video and electronically shared medical records) to treat CBOC patients with a newly emerging or chronic PTSD. We hypothesize that study participants randomized to the TOP intervention will receive higher quality of care and experience better outcomes compared to study participants randomized to treatment as usual.
Interventions
- OTHER Telemedicine Outreach for PTSD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 265 participants |
| Start Date | 2009-11 |
| Est. Completion | 2013-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00821678
The ClinicalTrials.gov registry entry for NCT00821678 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 265 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Telemedicine Outreach for PTSD is the first listed.
NCT00821678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00821678 about?
NCT00821678 is a clinical study titled "Telemedicine Outreach for Post Traumatic Stress in CBOCs". The purpose of this study is improved outcomes for veterans with Post Traumatic Stress Disorder (PTSD) treated in small VA Community Based Outpatient Clinics (CBOCs). Although psychotherapy and pharmacotherapy treatments for PTSD have been proven to be efficacious in controlled trials, geographic ba...
What is the current status of trial NCT00821678?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 265 participants. The study started on 2009-11. Estimated completion is 2013-09.
What interventions are being tested in trial NCT00821678?
The interventions under investigation include: Telemedicine Outreach for PTSD (OTHER).
Who is sponsoring clinical trial NCT00821678?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.